Restricted accessResearch articleFirst published online 2016-07
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin ( bla SHV-5,bla VEB-1 ),Carbapenem ( bla VIM-1 ),and Aminoglycoside ( rmtB ) Resistance Determinants by a Multidrug-Resistant Outbreak Clone
Providencia stuartii has emerged as an important nosocomial pathogen. We describe an outbreak due to a multidrug-resistant strain over a 4-month period in a critical care unit in Athens. Molecular typing revealed each of the isolates to be clonally related with coresistance to cephalosporins, carbapenems, aminoglycosides, and quinolones. Each isolate contained a 220-kb multi-replicon (IncA/C and IncR) conjugative plasmid encoding TEM-1, SHV-5, VEB-1, and VIM-1 β-lactamases and the 16S rDNA methylase RmtB. Antimicrobial therapy was unsuccessful in 3 of 6 cases, and resistance was readily transmissible to susceptible strains of Escherichia coli by transformation and conjugation. This highlights the clinical importance of P. stuartii and its ability to disseminate critical resistance determinants to other bacterial pathogens.
Get full access to this article
View all access options for this article.
References
1.
ArmbrusterC.E., SmithS.N., YepA., and MobleyH.L.2014. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii co-infection due to synergistic induction of urease activity. J. Infect. Dis., 209:1524–1532.
2.
ArpinC., ThabetL., YassineH., MessadiA.A., BoukadidaJ., DuboisV., Coulange-MayonnoveL., AndreC., and QuentinC.2012. Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit. Antimicrob. Agents Chemother., 56:1342–1349.
3.
AubertD., NaasT., LartigueM.F., and NordmannP.2005. Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrob. Agents Chemother., 49:3590–3591.
4.
BarlP., BedenićB., SardelićS., UzunovićS., VranešJ., and PlečkoV.2012. Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia. Med. Glas. (Zenica)., 9:317–324.
5.
BartonB.M., HardingG.P., and ZuccarelliA.J.1995. A general method for detecting and sizing large plasmids. Anal. Biochem., 226:235–240.
6.
CarattoliA.2011. Plasmids in Gram-negatives: molecular typing of resistance plasmids. Int. J. Med. Microbiol., 301:654–658.
7.
CarattoliA., BertiniA., VillaL., FalboV., HopkinsK.L., and ThrelfallE.J.2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods, 63:219–228.
8.
CiesielczukH., HornseyM., ChoiV., WoodfordN., and WarehamD.W.2013. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J. Med. Microbiol., 62:1823–1827.
9.
DalleneC., Da CostaA., DecreD., FavierC., and ArletG.2010. Development of a set of multiplex PCR assays for the detection of genes encoding β-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother., 65:490–495.
10.
de ChampsC., MonneC., BonnetR., SougakoffW., SirotD., ChanalC., and SirotJ.2001. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. Antimicrob. Agents Chemother., 45:1278–1280.
11.
DillonB., ThomasL., MohmandG., ZelynskiA., and IredellJ.2005. Multiplex PCR for screening of integrons in bacterial lysates. J. Microbiol. Methods, 62:221–232.
12.
DoukaE., PerivoliotiE., KraniotakiE., FountoulisK., EconomidouF., TsakrisA., SkoutelisA., and RoutsiC.2015. Emergence of a pandrug-resisatnt VIM-1 producing Providencia stuartii clonal strain causing an outbreak ina Grekk intensive care unit. Int. J. Antimicrob. Agents, 45:533–536.
13.
DrieuxL., Bourgeois-NicolaosN., CremniterJ., LawrenceC., JarlierV., Doucet-PopulaireF., and SougakoffW.2011. Accumlation of carbapenemase-producing Gram-negative bacteria in a single patient linked to the acquisition of multiple carbapenemase producers and to the in-vivo transfer of a plasmid encoding VIM-1. Int. J. Antimicrob. Agents, 38:179–180.
14.
DrieuxL., DecreD., FrangeulL., ArletG., JarlierV., and SougakoffW.2013. Complete nucleotide sequence of the large conjugative pTC2 multireplicon plasmid encoding VIM-1 metallo-β-lactamse. J. Antimicrob. Chemother., 68:97–100.
García-FernándezA., VillaL., MoodleyA., HasmanH., MiriagouV., GuardabassiL., and CarattoliA.2011. Multilocus sequence typing of IncN plasmids. J. Antimicrob. Chemother., 66:1987–1991.
17.
GiakkoupiP., TryfinopoulouK., PolemisM., PappaO., MiriagouV., and VatopoulosV.2015. Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area. Diagn. Microbiol. Infect. Dis., 82:62–64.
18.
HayakawaK., MarchaimD., DivineG.W., PogueJ.M., KumarS., LephartP., RiskoK., SobelJ.D., and KayeK.S.2012. Growing prevalence of Providencia stuartii associated with the increasad usage of colistin in a tertiary health care centre. Int. J. Infect. Dis., 16:e464–e648.
19.
HidalgoL., HopkinsK.L., WarehamD.W., GutierrezB., and Gonzalez-ZornB.2012. Association of extended-spectrum β-lactamase VEB-5 and 16S rRNA methyltransferase armA in Salmonella enterica from the United Kingdom. Antimicrob. Agents Chemother., 56:4985–4987.
20.
HordijkJ., WagenaarJ.A., and KantA.2013. Cross-sectional study on prevalence and molecular characteristics of plasmid mediated ESBL/AmpC-producing Escherichia coli isolated from veal calves at slaughter. PLoS One., 8:e65681.
21.
HornseyM., PheeL., and WarehamD.W.2011. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother., 55:5952–5954.
22.
HunterS.B., VauterinP., and Lambert-FairM.A.2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol., 43:1045–1050.
23.
IabadeneH., DallenneC., MessaiY., GenesteD., BakourR., and ArletG.2009. Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria. Antimicrob. Agents Chemother., 53:4043–4044.
LahlaouiH., and Ben MoussaM.2014. Detection of PER-1 extended-spectrum β-lactamase among nosocomial Providencia stuartii isolates in Tunisia. Tunis. Med., 92:258–261.
26.
LahlaouiH., PoirelL., MoussaM.B., FerjaniM., OmraneB., and NordmannP.2011. Nosocomial dissemination of extended-spectrum β-lactamase VEB-1a producing Providencia stuartii in a Tunisian Hospital. Eur. J. Clin. Microbiol. Infect. Dis., 30:1267–1270.
27.
Levy HaraG., GouldI., EndimianiA., PardoP.R., DaikosG., HsuehP.R., MehlerS., PetrikkosG., CasellasJ.M., DaciukL., PacielD., NovelliA., SaginurR., PrylukaD., MedinaJ., and SavioE.2013. Detection, treatment and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an international working group. J. Chemother., 25:129–140.
28.
MahroukiS., ChihiH., BourouisA., AyariK., FerjaniM., MoussaM.B., and BelhadjO.2015. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6')-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn. Microbiol. Infect. Dis., 81:50–52.
29.
MahroukiS., ChihiH., BourouisA., Ben MoussaM., and BelhadjO.2014. First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Ib-cr determinants. Braz. J. Infect. Dis., 18:211–214.
30.
MathersA., PeiranoJ.G., and PitoutJ.D.2015. The role of epidemic resistance plasmids and international high-risk clones in the spread of multi-drug resistant Enterobacteriaceae. Clin. Microbiol. Rev., 28:565–591.
31.
MavroidiA., LiakopoulosA., SarrouS., MiriagouV., and PetinakiE.2015. Identification and characterization of genetic structures coding for carbapenemases in Enterobacteria from Central Greece. Diagn. Microbiol. Infect. Dis., 81:47–49.
32.
McGannP., HangJ., CliffordR.J., YangY., KwakY.I., KuschnerR.A., LeshoE.P., and WatermanP.E.2012. Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan. Antimicrob. Agents Chemother., 56:1673–1679.
33.
MiriagouV., TzouvelekisL.S., FlevariK., TsakiriM., and DouzinasE.E.2007. Providencia stuartii with VIM-1 metallo-beta-lactamase. J. Antimicrob. Chemother., 60:183–184.
34.
MnifB., KtariS., ChaariA., MedhioubF., RhimiF., BouazizM., and HammamiA.2013. Nosocomial dissemination of Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospital. Antimicrob. Chemother., 68:329–332.
35.
NazikH., BektoreB., OngenB., OzyurtM., BaylanO., and HaznedarogluT.2011. Co-expression of plasmid-mediated quinolone resistance-qnrA1 and blaVEB-1 gene in a Providencia stuartii strain. New Microbiol., 34:225–228.
36.
Noppe-LeclercqI., WalletF., HaentjensS., CourcolR., and SimonetM.1999. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res. Microbiol., 150:317–322.
37.
O'HaraC.M., BrennerF.W., and MillerJ.M.2000. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin. Microbiol. Rev., 13:534–546.
38.
PoirelL., BrudererT., FreiR., BernabeuS., GraberP., and NordmannP.2008. Novel genetic structure associated with an extended-spectrum beta-lactamase PER-1 originating in Kosovo. J. Antimicrob. Chemother., 61:1392–1393.
39.
RendersN., RomlingY., VerbrughH., and van BelkumA.1996. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J. Clin. Microbiol., 34:3190–3195.
40.
RobinF., Aggoune-KhinacheN., DelmasJ., NaimM., and BonnetR.2010. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother., 54:466–470.
41.
SørensenA.H., HansenL.H., JohannesenE., and SorensenS.J.2003. Conjugative plasmid conferring resistance to olaquindox. Antimicrob. Agents Chemother., 47:798–799.
42.
TenoverF.C., ArbeitR.D., GoeringR.V., MickelsenP.A., MurrayB.E., PersingD.H., and SwaminathanB.1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33:2233–2239.
43.
TumbarelloM., CittonR., SpanuT., SanguinettiM., RomanoL., FaddaG., and CaudaR.2004. ESBL-producing multidrug–resistant Providencia stuartii infections in a university hospital. J. Antimirob. Chemother., 53:277–282.
44.
ZavasckiA.P., CarvalhaesC.G., da SilvaG.L., Tavares SoaresS.P., de AlcantaraL.R., EliasL.S., SandriA.M., and GalesA.C.2012. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect. Control Hosp. Epidemiol., 33:627–630.
